An expert involved in the first successful gene therapy trial for Huntington's Disease discusses the trial results and ...

The FDA has issued a CRL to Aldeyra Therapeutics for its new drug application (NDA) of reproxalap to treat dry eye disease.

Peter Fassler, Director Market Access at Gilead Sciences, highlighted the challenges facing the Netherlands and the rest of Europe in ensuring access to innovation therapies, at the Advanced Therapies ...

Backed by the venture portions of Eli Lily and Eisai, Excalipoint will look to progress the development of its six pipeline TCE therapies.

At Advanced Therapies, investors noted that early planning, adaptability and building trust will help a biotech startup succeed.

R1 Therapeutics has raised $77.5m in an oversubscribed Series A funding to advance AP306 for hyperphosphatemia in CKD ...

In a recent article, Sanofi presented preclinical data for an in vivo CAR-T platform that reengineers T cells directly within the body.

The court ruling reverses several changes by the CDC’s vaccine panel to childhood immunisation recommendations.

Sentynl Therapeutics has signed an agreement with PRG S&T to license Progerinin, an investigational molecule intended to ...

While the FDA can legally make prescription drugs OTC, legal expert Heidi Gertner notes that this wider shift depends on ...

GSK's RSV jab, Arexvy will now compete for market share with Pfizer’s Abrysvo and Moderna’s mRESVIA across the high-risk ...

The FDA has accepted for review Sun Pharmaceutical’s sBLA submitted for Ilumya to treat adults with active psoriatic arthritis.